Celebrex (celecoxib), the first COX-2 inhibitor

Searle and Pfizer are now marketing Celebrex (celecoxib), the first COX-2 inhibitor...in both the U.S. and Canada.

A second one, Vioxx (rofecoxib, Merck) is expected soon.

Celebrex and Vioxx will be used as alternatives to NSAIDs for arthritis and pain.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote